Saturday 17 October 2026 Export RDY’s income statement to Excel — free account

Dr. Reddy's Laboratories Ltd

RDY Healthcare Drug Manufacturers Specialty & Generic

Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025. In the quarter to June 2026, revenue fell 14.4%, EPS fell 70.0%, free cash flow fell 143.4% and total debt rose 34.0%, each against the same quarter a year earlier.

13.05 0.15 +1.16%

Follow RDY

Alert me

Market cap: $10.7B
P/E: 32.9×
Fwd P/E: 24.3×
Dividend yield: 0.00%
F-score: 4/9
Altman Z: 5.26
Beneish M: −2.59
Dividend safety: 74/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	36.49	25.79	18.23	17.26	+8 more quarters Free account
P/S ratio Full definition →	3.30	3.22	2.97	2.95
P/FCF ratio Full definition →	81.66	53.62	40.59	52.91
P/Operating CF Full definition →	(1,135.05)	77.38	99.07	68.88
P/B ratio Full definition →	2.78	2.84	2.79	2.86
Price to Tangible BV Full definition →	3.98	4.12	4.02	4.16
EV/Sales Full definition →	3.27	3.19	2.93	2.92
EV/EBITDA Full definition →	18.87	15.04	11.71	11.04
EV/Operating CF Full definition →	26.40	18.81	16.07	17.11
EV/FCF Full definition →	80.90	53.09	40.00	52.33
Quick Ratio Full definition →	1.16	1.13	1.18	1.11
Current Ratio Full definition →	1.90	1.80	1.88	1.85
Net Debt/EBITDA Full definition →	(1.07)	(4.36)	(0.78)	(0.50)
Debt/Assets Full definition →	12.51%	13.34%	12.03%	10.81%
Debt/Equity Full definition →	0.19	0.20	0.18	0.16
Asset Turnover Full definition →	0.57	0.60	0.66	0.68
Operating CF/Net income Full definition →	(0.21)	(13.83)	0.87	1.02
Capex/Depreciation Full definition →	(0.23)	(1.72)	(1.34)	(1.96)
Interest Coverage Full definition →	2.93	(2.99)	15.08	19.31
Research and Development Expense of Revenue Full definition →	7.15%	7.22%	7.05%	7.04%
Selling, General and Administrative Expense of Revenue Full definition →	35.64%	39.21%	30.85%	30.02%
Intangible Assets out of Total Assets Full definition →	0.20	0.20	0.20	0.21
Share Based Compensation of Revenue Full definition →	0.12%	0.00%	0.10%	0.10%
Graham Net Nets Full definition →	0.10	0.10	0.11	0.10
Graham Number Full definition →	6.83	7.67	9.33	9.45
Earnings Yield Full definition →	2.74%	3.88%	5.48%	5.79%
Free Cash Flow Yield Full definition →	1.22%	1.86%	2.46%	1.89%
Revenue per Share Full definition →	1.09	0.71	1.17	1.22
Operating CF per Share Full definition →	(0.01)	0.18	0.14	0.20
Capex per Share Full definition →	(0.02)	(0.11)	(0.09)	(0.13)
Free Cash Flow per Share Full definition →	(0.03)	0.07	0.05	0.07
Cash per Share Full definition →	1.10	1.13	1.11	0.95
Shareholders Equity per Share Full definition →	5.22	4.87	5.02	4.90
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	5.22	4.87	5.02	4.90
Free Cash Flow Full definition →	(23.00)	58.00	43.00	61.00
Working Capital Full definition →	1,501.00	1,432.00	1,550.00	1,448.00
Capital Expenditures Full definition →	(13.00)	(91.00)	(75.00)	(108.00)
Net Current Asset Value Full definition →	1,171.00	1,098.00	1,229.00	1,121.00
EV/EBIT Full definition →	29.99	21.18	15.10	13.96
Capex to Sales Full definition →	0.02	0.15	0.08	0.11
Price to Operating Income Full definition →	30.27	21.39	15.32	14.12
Other line items
Average Receivables Full definition →	1,086.00	1,068.50	1,113.50	1,054.50
Average Payables Full definition →	416.50	386.50	437.50	440.00
Average Inventory Full definition →	866.00	824.00	858.00	857.00
Average Assets Full definition →	6,069.00	5,973.50	5,944.50	5,834.00
Average Common Equity Full definition →	4,105.50	4,000.50	3,971.50	3,884.50

Fold the line items

Columns are period end dates

Stockrow Weekly